Evaluation of oxygen sensitivity of hyperpolarized helium imaging for the detection of pulmonary ischemia

2015 ◽  
Vol 75 (5) ◽  
pp. 2050-2054 ◽  
Author(s):  
Ronn P. Walvick ◽  
John P. Roche ◽  
Austin L. Reno ◽  
Matthew J. Gounis ◽  
Mitchell S. Albert
Author(s):  
ET Peterson ◽  
JH Holmes ◽  
A Dattawadkar ◽  
G Agrawal ◽  
J Dai ◽  
...  

Antioxidants ◽  
2021 ◽  
Vol 10 (2) ◽  
pp. 155
Author(s):  
Daniel Morales-Cano ◽  
Bianca Barreira ◽  
Beatriz De Olaiz Navarro ◽  
María Callejo ◽  
Gema Mondejar-Parreño ◽  
...  

Current approved therapies for pulmonary hypertension (PH) aim to restore the balance between endothelial mediators in the pulmonary circulation. These drugs may exert vasodilator effects on poorly oxygenated vessels. This may lead to the derivation of blood perfusion towards low ventilated alveoli, i.e., producing ventilation-perfusion mismatch, with detrimental effects on gas exchange. The aim of this study is to analyze the oxygen-sensitivity in vitro of 25 drugs currently used or potentially useful for PH. Additionally, the study analyses the effectiveness of these vasodilators in the pulmonary vs. the systemic vessels. Vasodilator responses were recorded in pulmonary arteries (PA) and mesenteric arteries (MA) from rats and in human PA in a wire myograph under different oxygen concentrations. None of the studied drugs showed oxygen selectivity, being equally or more effective as vasodilators under conditions of low oxygen as compared to high oxygen levels. The drugs studied showed low pulmonary selectivity, being equally or more effective as vasodilators in systemic than in PA. A similar behavior was observed for the members within each drug family. In conclusion, none of the drugs showed optimal vasodilator profile, which may limit their therapeutic efficacy in PH.


2009 ◽  
Vol 75 (1) ◽  
pp. 276-284 ◽  
Author(s):  
Jing Cai ◽  
Ke Sheng ◽  
Stanley H. Benedict ◽  
Paul W. Read ◽  
James M. Larner ◽  
...  

2010 ◽  
Vol 63 (6) ◽  
pp. 1448-1455 ◽  
Author(s):  
Nicholas J. Tustison ◽  
Talissa A. Altes ◽  
Gang Song ◽  
Eduard E. de Lange ◽  
John P. Mugler ◽  
...  

2003 ◽  
Vol 306 (2) ◽  
pp. 450-456 ◽  
Author(s):  
Laura Conforti ◽  
Koichi Takimoto ◽  
Milan Petrovic ◽  
Olaf Pongs ◽  
David Millhorn

2006 ◽  
Vol 100 (2) ◽  
pp. 587-593 ◽  
Author(s):  
Elizabeth M. Wagner ◽  
Irina Petrache ◽  
Brian Schofield ◽  
Wayne Mitzner

Cellular remodeling during angiogenesis in the lung is poorly described. Furthermore, it is the systemic vasculature of the lung and surrounding the lung that is proangiogenic when the pulmonary circulation becomes impaired. In a mouse model of chronic pulmonary thromboembolism, after left pulmonary artery ligation (LPAL), the intercostal vasculature, in proximity to the ischemic lung, proliferates and invades the lung ( 12 ). In the present study, we performed a detailed investigation of the kinetics of remodeling using histological sections of the left lung of C57Bl/6J mice after LPAL (4 h to 20 days) or after sham surgery. New vessels were seen within the thickened visceral pleura 4 days after LPAL predominantly in the upper portion of the left lung. Connections between new vessels within the pleura and pulmonary capillaries were clearly discerned by 7 days after LPAL. The visceral pleura and the lung parenchyma showed intense tissue remodeling, as evidenced by markedly elevated levels of both proliferating cell nuclear antigen and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling positive cells. Rapidly dividing cells were predominantly macrophages and type II pneumocytes. The increased apoptotic activity was further quantified by caspase-3 activity, which showed a sixfold increase relative to naive lungs, by 24 h after LPAL. Because sham surgeries had little effect on measured parameters, we conclude that both thoracic wound healing and pulmonary ischemia are required for systemic neovascularization.


2003 ◽  
Vol 278 (51) ◽  
pp. 51422-51432 ◽  
Author(s):  
Matthew E. Hartness ◽  
Stephen P. Brazier ◽  
Chris Peers ◽  
Alan N. Bateson ◽  
Michael L. J. Ashford ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document